Literature DB >> 358479

Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).

H M Jansen, T H The, G C de Gast, M T Esselink, A M van der Wal, N G Orie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 358479      PMCID： PMC470909          DOI： 10.1136/thx.33.4.429

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  39 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

2.  Immunogenicity of tumor antigens.

Authors:  R B Herberman; D A Campbell; R K Oldham; G D Bonnard; C C Ting; H T Holden; M Glaser; J Djeu; R Oehler
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

Review 3.  Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants.

Authors:  R C Bast; B S Bast
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

Review 4.  Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.

Authors:  M J Mastrangelo; D Berd; R E Bellet
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

Review 5.  Immunology of bronchial carcinoma.

Authors:  D A Evans
Journal:  Thorax       Date:  1976-10       Impact factor: 9.139

6.  Intrapleural B.C.G. immunostimulation in lung cancer.

Authors:  M F McKneally; C M Maver; H W Kausel
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

7.  New method of immunotherapy for lung cancer.

Authors:  E C Holmes; K P Ramming; J Mink; W F Coulson; D L Morton
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

Review 8.  Immunotherapy as related to lung cancer: a review.

Authors:  E M Hersh; G M Mavligit; J U Gutterman
Journal:  Semin Oncol       Date:  1974-09       Impact factor: 4.929

9.  Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.

Authors:  Y Yamamura; I Azuma; T Taniyama; K Sugimura; F Hirao; R Tokuzen; M Okabe; W Nakahara; K Yasumoto; M Ohta
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

10.  5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus.

Authors:  H Stott; R J Stephens; W Fox; D C Roy
Journal:  Br J Cancer       Date:  1976-08       Impact factor: 7.640
View more
  5 in total

1.  Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.

Authors:  H M Jansen; T H The; N G Orie
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

2.  Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.

Authors:  W Bakker; J M Nijhuis-Heddes; A M Wever; A Brutel de la Rivière; E A van der Velde; J H Dijkman
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

Review 3.  Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention.

Authors:  Martin R Jadus; Josephine Natividad; Anthony Mai; Yi Ouyang; Nils Lambrecht; Sandor Szabo; Lisheng Ge; Neil Hoa; Maria G Dacosta-Iyer
Journal:  Clin Dev Immunol       Date:  2012-07-29

Review 4.  Immunotherapy in lung cancer.

Authors:  M Al-Moundhri; M O'Brien; B E Souberbielle
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

5.  Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication.

Authors:  J Bancewicz; K C Calman; S G Macpherson; C S McArdle; J G McVie; M Soukop
Journal:  J R Soc Med       Date:  1980-03       Impact factor: 18.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.